HomeRYTM • NASDAQ
add
Rhythm Pharmaceuticals Inc
Previous close
$66.18
Day range
$66.24 - $67.85
Year range
$38.85 - $68.58
Market cap
4.30B USD
Avg Volume
624.93K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
(USD) | Mar 2025info | Y/Y change |
---|---|---|
Revenue | 32.70M | 25.94% |
Operating expense | 76.06M | 7.66% |
Net income | -49.50M | 64.99% |
Net profit margin | -151.35 | 72.20% |
Earnings per share | -0.81 | 65.53% |
EBITDA | -46.62M | 0.98% |
Effective tax rate | -0.16% | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Mar 2025info | Y/Y change |
---|---|---|
Cash and short-term investments | 314.49M | 56.31% |
Total assets | 386.68M | 49.50% |
Total liabilities | 223.60M | 13.46% |
Total equity | 163.09M | — |
Shares outstanding | 63.62M | — |
Price to book | 220.60 | — |
Return on assets | -30.17% | — |
Return on capital | -42.35% | — |
Cash Flow
Net change in cash
(USD) | Mar 2025info | Y/Y change |
---|---|---|
Net income | -49.50M | 64.99% |
Cash from operations | -40.35M | 0.96% |
Cash from investing | 24.81M | -17.43% |
Cash from financing | 32.50M | 665.94% |
Net change in cash | 16.96M | 360.05% |
Free cash flow | -24.65M | 63.58% |
About
Founded
Nov 2008
Headquarters
Website
Employees
283